Mr. Tom Willis

• 
  canmedbio.bio.org/opencms/BECIF/program/details/f5.jsp - [Cached Version]
  Published on: 10/6/2008    Last Visited: 11/17/2007  

  Thomas D. Willis, PhD, Chief Scientific Officer and Co-founder, ParAllele Bioscience, Inc.

• 
  www.indexventures.com/cgi-local/ivw_team_detail_xy.cgi? - [Cached Version]
  Published on: 12/12/2007    Last Visited: 12/12/2007  

  Thomas WillisIndex Ventures
  ...
  Thomas Willis
  ...
  Thomas Willis
  
  Venture Advisor
  
  Alongside his current role as Vice President for DNA Product Marketing at Affymetrix, Tom acts as Venture Advisor to the Index team.Prior to the acquisition of ParAllele by Affymetrix, Tom was the CEO and co-founder of Parallele Bioscience.Before founding ParAllele, Tom served as Associate Director of the Stanford Genome Technology Center at Stanford University, directing the institution's technology development efforts.Dr. Willis received his doctorate in Physics from Stanford University in 1996.

• 
  www.indexventures.com/news/index/news_id/105 - [Cached Version]
  Published on: 10/30/2002    Last Visited: 6/2/2008  

  The award of this grant validates our approach and recognizes our rapid progress as a company,' said Tom Willis, Ph.D., President and CEO of ParAllele BioScience, whose company was launched only ten months ago.
  
  Dr. Willis continued, 'Our selection to participate in the International HapMap Project will establish ParAllele as the leading provider of high-throughput genomic screening technologies and demonstrate the commercial value of our Molecular Inversion Probe assay.
  ...
  Tom Willis, Ph.D.

• 
  www.corporate-ir.net/ireye/ir_site.zhtml?ticker=AFFX&sc - [Cached Version]
  Published on: 8/15/2006    Last Visited: 5/10/2007  

  "It is critical to analyze thousands of samples in order to identify genetic variations associated with complex diseases such as autism," said Tom Willis, Ph.D., vice president, DNA Marketing at Affymetrix.

• 
  www.corporate-ir.net/ireye/ir_site.zhtml?ticker=AFFX&sc - [Cached Version]
  Published on: 3/8/2006    Last Visited: 5/10/2007  

  "Whole-genome association studies are accelerating genetic discoveries in labs around the world," said Tom Willis, Ph.D, vice president of DNA Marketing at Affymetrix.

• 
  investor.affymetrix.com/phoenix.zhtml?c=116408&p=irol-n - [Cached Version]
  Published on: 8/2/2006    Last Visited: 8/5/2007  

  "We plan on expanding the Affymetrix control program to include data from populations around the world to better support the broad spectrum of sample types used for genetic studies," said Tom Willis, Ph.D., vice president, DNA Marketing at Affymetrix.

• 
  www.smartbrief.com/news/aaaa/industryBW-detail.jsp?id=8 - [Cached Version]
  Published on: 10/6/2008    Last Visited: 7/15/2008  

  SpinX Technologies boasts a Board of Directors composed of leading businessmen, venture capital experts and researchers Sam Eletr (CEO, Population Genetics), Donald Fitzmaurice (Director, DFJ ePlanet Ventures), Mir Imran (Venture Partner and Senior Advisor, DFJ ePlanet), Thierry Jean (Chairman and CEO, Cerep), Seppo Mäkinen (Senior Partner, BioFund Management Oy Ltd), Philippe Peltier (Partner, Auriga Partners), Thomas Willis (VP for DNA Marketing, Affymetrix), Giuseppe Zocco (General Partner, Index Ventures), and Piero Zucchelli (Founder and CSO of SpinX Technologies).

• 
  www.bionity.com/news/e/66613/ - [Cached Version]
  Published on: 10/6/2008    Last Visited: 2/3/2008  

  SpinX Technologies boasts a Board of Directors composed of Sam Eletr (CEO, Population Genetics), Donald Fitzmaurice (Director, DFJ ePlanet Ventures), Mir Imran (Venture Partner and Senior Advisor, DFJ ePlanet), Thierry Jean (Chairman and CEO, Cerep), Seppo Mäkinen (Senior Partner, BioFund Management Oy Ltd), Philippe Peltier (Partner, Auriga Partners), Thomas Willis (VP for DNA Marketing, Affymetrix), Giuseppe Zocco (General Partner, Index Ventures), and Piero Zucchelli (Founder and CSO of SpinX Technologies).

• 
  www.indexventures.com/news/index/news_id/79 - [Cached Version]
  Published on: 5/31/2005    Last Visited: 6/2/2008  

  Affymetrix has been a vital collaborative partner in helping bring our proprietary technology to market," said Tom Willis, Ph.D., Chief Scientific Officer and co-founder of ParAllele.

• 
  www.corporate-ir.net/ireye/ir_site.zhtml?ticker=AFFX&sc - [Cached Version]
  Published on: 3/18/2003    Last Visited: 5/10/2007  

  "ParAllele is now positioned to deliver a wide range of SNP discovery and genotyping solutions," said Tom Willis, Ph.D., Chief Executive Officer of ParAllele.

Page:  1 2 3 4